Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibitors is associated with poor outcomes in metastatic...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2023-09-01
|
| 叢編: | Immuno-Oncology and Technology |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S259001882300014X |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|